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Edited by Veli-Pekka LehtoAbstract Parasympathetic (cholinergic) innervation is impli-
cated in the stimulation of hepatic glucose uptake by portal vein
hyperglycaemia. We determined the direct eﬀects of acetylcho-
line on hepatocytes. Acute exposure to acetylcholine mimicked
insulin action on inactivation of phosphorylase, stimulation of
glycogen synthesis and suppression of phosphoenolpyruvate car-
boxykinase mRNA levels but with lower eﬃcacy and without
synergy. Pre-exposure to acetylcholine had a permissive eﬀect
on insulin action similar to glucocorticoids and associated with
increased glucokinase activity. It is concluded that acetylcholine
has a permissive eﬀect on insulin action but cannot fully account
for the rapid stimulation of glucose uptake by the portal signal.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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The extent by which the liver clears glucose from the blood
in conditions of elevated blood glucose concentration is depen-
dent on the glucose load, the route of delivery of glucose to the
liver and the insulin to glucagon ratio [1]. Insulin is more eﬀec-
tive at stimulating hepatic glucose uptake and glycogen storage
when glucose is delivered via the portal vein as opposed to the
hepatic artery or the peripheral circulation [2–4]. This mecha-
nism which is known as the ‘‘Portal Signal’’ is dependent on an
intact nerve supply to the liver [5–7] and is thought to involve
glucose sensing in the portal vein [8] and altered transmission
of parasympathetic (cholinergic) and sympathetic (noradrener-
gic) stimuli to the liver [9–11]. Activation of sympathetic nerves
directly stimulates glucose output by hepatocytes through the
neurotransmitters noradrenaline and ATP via adrenergic and
P2Y receptors, respectively [12]. It is generally assumed that
activation of parasympathetic nerves stimulates hepatic glu-
cose uptake and suppresses glucose production through release
of acetylcholine. This is based largely on studies in vivo and onAbbreviations: GK, glucokinase; glucose 6-P, glucose 6-phosphate;
MEM, minimum essential medium; OBAA, 3-(4-octadecyl)-benzoyl-
acrylic acid; PDE, cAMP phosphodiesterase; PEPCK, phosphoenol-
pyruvate carboxykinase
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doi:10.1016/j.febslet.2007.07.026the in situ perfused liver. Pharmacological inhibition of cholin-
ergic nerves with atropine counteracted insulin-stimulated he-
patic glucose uptake in the cat, dog and rat [4,9,13–15].
However, studies on freshly isolated hepatocytes have not pro-
vided evidence for greater eﬃcacy of acetylcholine compared
with insulin [16]. Hepatocytes in monolayer culture are a better
model for studying insulin action, because pre-culture with low
concentrations of glucocorticoid has a permissive eﬀect on
insulin action [17,18]. In this study, we used hepatocytes in
monolayer culture to evaluate the direct eﬀects of acetylcholine
on glucose metabolism and insulin action during either acute
exposure to acetylcholine or after pre-exposure to acetylcho-
line.2. Materials and methods
2.1. Isolation and culture of hepatocytes
Hepatocytes were isolated by collagenase perfusion of the liver from
male Wistar rats fed ad libitum [19]. The cells were seeded in minimum
essential medium (MEM) supplemented with 5% newborn calf-serum
and after cell attachment (4 h) they were cultured in serum-free
MEM containing 5 mM glucose and the concentrations of dexameth-
asone or acetylcholine as indicated [19].
2.2. Metabolic incubations
After 16 h pre-culture in serum-free MEM without or with dexa-
methasone or acetylcholine, the medium was replaced by serum-free
MEM containing 15 mM glucose and other additions as indicated
and incubations were for 1–3 h. For determination of glycogen synthe-
sis the medium was supplemented with [U–14C] glucose (2 lCi/ml).
Glycogen synthesis was determined after 3 h incubation by ethanol
precipitation as previously described [19]. Parallel 1 h incubations
without radiolabel were performed for determination of glucose
6-phosphate (glucose 6-P) [20] and enzyme activities.
2.3. Enzyme and protein determination
For determination of glucokinase, cells were permeabilised with dig-
itonin and glucokinase was assayed as in [21]. Phosphorylase-a and
glycogen synthase were assayed as in [19]. cAMP phosphodiesterases
(PDE), type-3 (PDE3) and type-4 (PDE4) were assayed as in [22] ex-
cept that alkaline phosphatase (0.3 U/sample) was used instead of
snake venom. Phosphorylation of protein kinase B on ser-473 was
determined by immunoblotting [23].
2.4. mRNA determination
Total RNA (1 lg) was extracted from hepatocytes using Trizol
(Invitrogen) and treated with RNase free DNase I (Roche). cDNA
(50 ng) was synthesised using Superscript II (Invitrogen) in the pres-
ence of random hexamers (GE Healthcare UK Ltd.) and dNTP mix
(Bioline). Real-time RT-PCR analysis was performed starting with
50 ng cDNA in a PCR reaction (10 ll) containing 0.5 lM primers,
3 mM MgCl2 and 1· Light Cycler FastStart DNA Master SYBR
Green I using a Light Cycler (Roche).blished by Elsevier B.V. All rights reserved.
3956 L.J. Hampson, L. Agius / FEBS Letters 581 (2007) 3955–3960The primers used were; glucokinase (GK), sense, 5 0–CAACATCG-
TAGGACTTCTCCG–3 0, anti-sense, 5 0-GGCGGTCTTCATAG-
TAGCAG-30; phosphoenolpyruvate carboxykinase (PEPCK), sense,
5 0-TGGCTACGTCCCTAAGGAA-30, anti-sense, 5 0-GGTCCTCCA-
GATACTTGTCGA-3 0. PCR was performed by pre-incubation for
10 min at 95 C for initial denaturation followed by 40 cycles consisting
of 95 C for 15 s, 58 C for 7 s and 72 C for 15 s were performed. Cycl-
ophillin wasmeasured as an invariant control and the relative changes in
mRNA for a given gene were corrected for cyclophillin mRNA values.
PCR speciﬁcity and product length were checked by gel electrophoresis.
2.5. Analysis
Results are expressed as means ± S.E.M for the number of hepato-
cyte preparations indicated. Statistical analysis was by the paired t-test,
except where indicated which was by 2-way ANOVA.3. Results
3.1. Acute eﬀects of acetylcholine on glycogen metabolism
Because glucocorticoids have a permissive eﬀect on insulin
action [17] we compared the eﬀects of acetylcholine and a max-
imally eﬀective concentration of insulin (10 nM) in hepatocytes
pre-cultured without or with low concentrations of dexameth-
asone (Fig. 1). Acetylcholine caused a small stimulation of gly-
cogen synthesis after pre-culture without dexamethasone that
was comparable to the stimulation by insulin (Fig. 1A and
B). However, unlike insulin action, the stimulation by acetyl-0 1 10
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Fig. 1. Short-term eﬀects of acetylcholine and insulin on glycogen synthesis
with dexamethasone (1 or 10 nM) and then incubated without or with 250
glycogen synthesis and phosphorylase-a activity as described in Section 2. (A)
by acetylcholine and insulin. (C) Inactivation of phosphorylase (% decrease
*P < 0.05, **P < 0.005 relative to control; #P < 0.05 relative to insulin.
phosphorylase-a (mU/mg), means of n = 5, in the absence of dexamethaso
indicated.choline was not enhanced by pre-culture with dexamethasone.
The eﬀects of acetylcholine and insulin were additive and there
was no evidence for synergy. Like insulin action, the stimula-
tion of glycogen synthesis by acetylcholine was associated with
inactivation of phosphorylase (conversion of phosphorylase-a
to phosphorylase-b) and there was an inverse correlation be-
tween glycogen synthesis and phosphorylase-a during incuba-
tion with insulin and/or acetylcholine (Fig. 1C and D).
Acetylcholine and insulin caused comparable activation of
glycogen synthase and the combined eﬀects were less than
additive (insulin, 25.7 ± 2.5, acetylcholine 19.3 ± 8.9; acetyl-
choline + insulin 32.4 ± 5.0, % increase above control). The
stimulation of glycogen synthesis by acetylcholine was blocked
by 10 lM atropine (control 13.2 ± 4.3; acetylcholine 16.1 ±
4.5, P < 0.005; atropine 13.9 ± 3.9; atropine + acetylcholine,
14.2 ± 3.0, P > 0.05, nmol/3 h/mg1) consistent with involve-
ment of muscarinic receptors [24]. Unlike insulin action acetyl-
choline did not cause phosphorylation of protein kinase B on
ser-473 (results not shown) and stimulation of glycogen syn-
thesis was blocked by 3-(4-octadecyl)-benzoylacrylic acid
(OBAA) (Fig. 2) an inhibitor of phospholipase A2 [25].
3.2. Counterregulatory eﬀects of acetylcholine on glucagon
action
Glucagon stimulates glycogenolysis acutely by activation of
phosphorylase (conversion of phosphorylase-b to phosphory-0 1 10
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Fig. 2. Counteraction of acetylcholine eﬀect by OBAA. Hepatocytes
were pre-incubated without or with 10 lM OBAA for 15 min before
incubating without or with 250 lM acetylcholine (Ach) and 10 nM
insulin (Ins) for determination of glycogen synthesis (% control).
Means ± S.E.M., n = 5. *P < 0.05, **P < 0.005 relative to correspond-
ing control.
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tion of gluconeogenic enzymes. Acetylcholine like insulin par-
tially counteracted the eﬀects of glucagon on activation of
phosphorylase and the eﬀects of insulin and acetylcholine were
additive at 0.5 nM glucagon but not at higher concentrations0.1 0.5 1.0 10.0
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Fig. 3. Acetylcholine partially counteracts glucagon action. (A)
Hepatocytes were pre-incubated without or with 250 lM acetylcholine
(Ach) and/or 10 nM insulin (Ins) for 60 min before addition of
glucagon (5 min) at concentrations shown for determination of
phosphorylase-a. Means ± S.E.M., n = 4, *P < 0.05, **P < 0.005 rela-
tive to control, 2-way ANOVA. (B) Hepatocytes were pre-cultured
with 100 nM dexamethasone and then incubated without or with
250 lM acetylcholine for 10 min before addition of 0.2 nM glucagon
(3 h) for determination of PEPCK mRNA as described in Section 2.
Means ± S.E.M., n = 6, ##P < 0.005 relative to glucagon alone.(Fig. 3A). Acetylcholine suppressed PEPCK mRNA levels
but with lower eﬃcacy than insulin (Fig. 3B).
3.3. Permissive eﬀect of acetylcholine on insulin action
Because hepatic denervation is associated with insulin resis-
tance and decreased hepatic glycogen storage [14,26] implicat-
ing a chronic role for parasympathetic stimulation in
regulating hepatic glucose metabolism we tested the eﬀects of
pre-culture with acetylcholine on the subsequent short-term re-
sponse to insulin. Pre-culture of hepatocytes with acetylcholine
mimicked the permissive eﬀect of dexamethasone on insulin
action on glycogen synthesis and inactivation of phosphory-
lase (Fig. 4A–D). These eﬀects of acetylcholine were associated
with an increase in glucokinase activity (Fig. 4E) and in the
glucose-dependent increase in glucose 6-P (Fig. 4F), indicating
that the inactivation of phosphorylase and stimulation of gly-
cogen synthesis can be in part explained by the elevated glu-
cose 6-P, which causes depletion of phosphorylase-a [27].
Acetylcholine potentiated the increase in glucokinase mRNA
caused by insulin (Fig. 5) but had no eﬀect in the absence of
insulin (results not shown). The eﬀects of acetylcholine are un-
likely to be due to changes in cAMP, because acetylcholine un-
like dexamethasone [28] did not aﬀect the activity of PDE3 and
PDE4 (Fig. 6).4. Discussion
The contribution of the Portal Signal to regulation of hepa-
tic glucose balance has been determined experimentally by
comparing rates of hepatic glucose production or uptake when
a glucose load is administered either through the portal vein or
the hepatic artery/peripheral circulation at the same clamped
level of insulin. These studies on both man and animal models
support a major contribution of the Portal Signal to stimula-
tion of hepatic glucose uptake in hyperinsulineamic conditions
[1–3]. The involvement of the parasympathetic innervation in
the Portal Signal is supported by the inhibitory eﬀect of atro-
pine, an antagonist of muscarinic receptors [4,9] and by
chronic denervation [5–7] though not by acute cooling of the
vagal nerve [29,30]. If the contribution of cholinergic mecha-
nisms to the stimulation of hepatic glucose uptake were due
to a direct eﬀect of acetylcholine on hepatocytes as opposed
to either haemodynamic changes or indirect eﬀects involving
release of other neurotransmitters (or incretins), then acetyl-
choline would be expected to have either a large stimulatory
eﬀect on glycogen synthesis in comparison with insulin action
or alternatively a synergistic eﬀect with insulin. An indication
of synergy between acetylcholine and insulin by either direct
or indirect mechanisms was provided in the in situ perfused
rat liver [4]. However, this experimental model cannot exclude
indirect eﬀects on the liver.4.1. Lack of synergy during acute exposure to insulin and
acetylcholine
In this study, we used short-term primary hepatocyte cul-
tures (within 24 h of isolation) to compare the eﬀects of acetyl-
choline and insulin on glucose metabolism. The key advantage
of this model is that it allows pre-incubation of hepatocytes in
deﬁned substrate and hormone conditions prior to study of the
short-term eﬀects of insulin. In this model, low concentrations
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Fig. 4. Pre-exposure to acetylcholine mimics the permissive eﬀect of glucocorticoid. Hepatocytes were pre-cultured for 16 h without or with 50 lM
acetylcholine (ACh) and 10 nM dexamethasone (Dex). The eﬀects of insulin on glycogen synthesis (A and B) and phosphorylase-a (C and D) activity
were then determined. (E) Glucokinase activity. (F) Glucose 6-P determined after 1 h incubation with the glucose concentrations shown. *P < 0.05,
**P < 0.005 relative to corresponding control; #P < 0.05 relative to no insulin.
3958 L.J. Hampson, L. Agius / FEBS Letters 581 (2007) 3955–3960of glucocorticoid have a permissive eﬀect on insulin stimula-
tion of glycogen synthesis which is mediated by inactivation
of phosphorylase [17]. The experiments testing the eﬀects of
acute exposure to acetylcholine show that the stimulation of
glycogen synthesis is either smaller (<50%) than the stimula-
tion by insulin in cells pre-treated with glucocorticoid or it is
at best comparable to the small eﬀect of insulin in cells pre-cul-
tured without glucocorticoid. There was no evidence for syn-
ergy between acetylcholine and insulin on either glycogen
synthesis or phosphorylase inactivation. The counteraction
of glucagon induction of PEPCK mRNA levels was also less
than the eﬀect of insulin.
Intraportal hyperglycaemia accounts for at least 60% of the
stimulation of hepatic glucose uptake, and is more rapid than
insulin-stimulated hepatic glucose uptake [36,37]. The lower
eﬃcacy of acetylcholine compared with insulin and the lack
of synergy does not support a major direct role for acetylcho-line in mediating the stimulation of hepatic glucose uptake by
intraportal hyperglycaemia.
The counteraction by atropine of the glycogenic eﬀect of
acetylcholine is consistent with involvement of muscarinic
receptors [24]. The M1–M5 muscarinic receptors are coupled
to either Gq proteins resulting in activation of phospholipase
C and phospholipase D leading to activation of phospholipase
A2 or to Gi proteins leading to a decrease in cAMP [31]. The
counteraction of the action of acetylcholine by the phospholi-
pase A2 inhibitor implicates a role for bioactive mediators
downstream of phospholipase A2 in stimulating glycogenesis.
Although activation of phospholipase A2 can mediate the
cytotoxic eﬀects of arachidonic acid in hepatocytes [32], it is
possible that modest activation of the enzyme can mimic insu-
lin action by an analogous mechanism as has been shown for
reactive oxygen species (ROS), which are implicated in insulin
action [33]. ROS generated endogenously and also exogenous
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Fig. 5. Acetylcholine potentiates insulin induction of glucokinase
mRNA. Hepatocytes were cultured for 16 h with 10 nM insulin
without or with 200 lM acetylcholine. Means ± S.E.M., n = 5,
*P < 0.005.
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indicated. Means ± S.E.M, n = 3, *P < 0.05 relative to control.
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mRNA levels in hepatoma cells [34] and by stimulating glucose
metabolism in adipocytes [33] and glycogen synthesis in hepa-
tocytes (A. Zaidi and L. Agius, unpublished results). PI-3-ki-
nase independent and Gi-alpha dependent pathways have
been implicated in the mechanism by which insulin generates
ROS [33,35]. The additive as opposed to synergistic eﬀects of
insulin and acetylcholine on glycogen synthesis are consistent
with generation of ROS via Gi-alpha (insulin [35]) and Gq
(acetylcholine), which may impact glucose metabolism through
a common mechanism.
4.2. Permissive eﬀect of acetylcholine on insulin action
Pre-culture of hepatocytes with low concentrations of gluco-
corticoids has a permissive eﬀect on insulin action on glycogen
synthesis, inactivation of phosphorylase [17] and induction of
glucokinase mRNA [18]. This eﬀect is not due to increased
insulin binding, activation of the insulin receptor kinase or
activation of protein kinase B which are not aﬀected by gluco-
corticoids [17]. The additive eﬀects of insulin and acetylcholine
in the acute exposure studies and the lack of eﬀect of acetyl-
choline on phosphorylation of protein kinase B, is consistent
with a signaling pathway independent of protein kinase B.
One of the well-characterized eﬀects of glucocorticoids in
hepatocytes is the suppression of cAMP-phosphodiesteraseactivity [28]. However, acetylcholine unlike dexamethasone
did not aﬀect the activities of PDE3 and PDE4. It seems unli-
kely therefore that altered cAMP turnover accounts for the
permissive eﬀects of acetylcholine. The lack of additive eﬀects
of acetylcholine and glucocorticoids in these experiments sug-
gests that whilst glucocorticoids may activate various signaling
pathways, a component shared with the acetylcholine mecha-
nism may mediate the permissive eﬀect on insulin action.
The permissive eﬀect of acetylcholine on insulin action is con-
sistent with previous in vivo studies showing that chronic liver
denervation results in a reduction in insulin responsiveness
that is reversed by administration of acetylcholine [26].
In summary, this study supports the conclusion that whilst
both the acute and chronic eﬀects of acetylcholine on glycogen
synthesis are consistent with an anabolic role on glycogen
metabolism that is mediated by either inactivation of phos-
phorylase or by increased glucokinase activity, the magnitude
of these direct eﬀects of acetylcholine is not suﬃcient to explain
the large stimulation of hepatic glucose uptake by intraportal
infusion of glucose [1,2] described as the ‘‘Portal Signal’’.
The possibility needs to be considered that other neurotrans-
mitters (or incretins) with greater eﬃcacy than acetylcholine
and acting independently or synergistically with insulin and
acetylcholine may be involved in the stimulation of hepatic
glucose uptake by intraportal hyperglycaemia.
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